tradingkey.logo

Insulet rises after Q1 results

ReutersMay 9, 2025 12:10 PM

Medical device maker Insulet's PODD.O shares rise 10.2% to $283.20 premarket

Insulet late on Thursday beat Q1 profit estimates, buoyed by strong demand for its wearable insulin pumps

Company earned $1.02 per share, above analysts' average estimate of 80 cents per share - data compiled by LSEG

Company now expects its annual revenue to grow between 19% and 22%, compared with its previous projection of 16% to 20%

Company's Q1 total revenue increased 28.8% to $569 million, compared with analysts' estimates of $543.4 million

As of last close, stock down 1.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI